{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:27:18Z","timestamp":1761182838455,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/s10156-009-0689-5","type":"journal-article","created":{"date-parts":[[2009,8,17]],"date-time":"2009-08-17T06:16:20Z","timestamp":1250489780000},"page":"219-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm"],"prefix":"10.1016","volume":"15","author":[{"given":"Naoki","family":"Aikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kusachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Takesue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideharu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-009-0689-5_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3314\/jjmm.40.135","article-title":"Study of the frequency of deep-seated mycosis in critical care centers: relationship between fungal infection risk and disease state and patient severity (in Japanese)","volume":"40","author":"Tanaka","year":"1999","journal-title":"Jpn J Med Mycol"},{"key":"10.1007\/s10156-009-0689-5_bib0010","first-page":"127","article-title":"Current state of deep-seated mycosis in emergency medicine (in Japanese)","volume":"12","author":"Matsuoka","year":"2000","journal-title":"Japan Society for Surgical Infection"},{"key":"10.1007\/s10156-009-0689-5_bib0015","first-page":"721","article-title":"Diagnosis and treatment of deep candidiasis in non-neutropenic patients: toward a consensus in Japan","volume":"51","author":"Aikawa","year":"1998","journal-title":"Jpn J Antibiotics"},{"key":"10.1007\/s10156-009-0689-5_bib0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1179\/joc.1999.11.6.504","article-title":"Role of newer azoles in surgical patients","volume":"11","author":"Patterson","year":"1999","journal-title":"J Chemother"},{"key":"10.1007\/s10156-009-0689-5_bib0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/342300","article-title":"Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999","volume":"35","author":"Trick","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-009-0689-5_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10156-002-0182-X","article-title":"Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan","volume":"8","author":"Aikawa","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-009-0689-5_bib0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1439-0507.2001.00649.x","article-title":"Fluconazole vs amphotericin B for the management of candidaemia in adults: a meta-analysis","volume":"44","author":"Kontoyiannis","year":"2001","journal-title":"Mycoses"},{"key":"10.1007\/s10156-009-0689-5_bib0040","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/JCM.40.3.852-856.2002","article-title":"Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000","volume":"40","author":"Pfaller","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1007\/s10156-009-0689-5_bib0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(95)00010-0","article-title":"The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance","volume":"100","author":"Nguyen","year":"1996","journal-title":"Am J Med"},{"key":"10.1007\/s10156-009-0689-5_bib0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005792-199907000-00002","article-title":"Candida glabrata fungemia. Clinical features of 139 patients","volume":"78","author":"Gumbo","year":"1999","journal-title":"Medicine"},{"key":"10.1007\/s10156-009-0689-5_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.44.1.57-62.2000","article-title":"In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi","volume":"44","author":"Tawara","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-009-0689-5_bib0060","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.44.3.614-618.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis","volume":"44","author":"Ikeda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-009-0689-5_bib0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.44.3.619-621.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis","volume":"44","author":"Matsumoto","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-009-0689-5_bib0070","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.44.6.1728-1730.2000","article-title":"Efficacy of FK463, a (1,3)-\u03b2-D-glucan synthase inhibitor, in disseminated azole-resistant Candida albicans infection in mice","volume":"44","author":"Maesaki","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-009-0689-5_bib0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000057666","article-title":"In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds","volume":"48","author":"Nakai","year":"2002","journal-title":"Chemotherapy"},{"key":"10.1007\/s10156-009-0689-5_bib0080","first-page":"308","article-title":"Susceptibility of clinical isolates of Candida and Aspergillus species to micafungin (in Japanese)","volume":"54","author":"Kobayashi","year":"2006","journal-title":"Jpn J Chemotherapy"},{"key":"10.1007\/s10156-009-0689-5_bib0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3314\/jjmm.47.293","article-title":"Efficacy of micafungin sodium on fungal infection in critical care: statistics from three medical institutions in Chiba Prefecture (in Japanese)","volume":"47","author":"Tateishi","year":"2006","journal-title":"Jpn J Med Mycol"},{"key":"10.1007\/s10156-009-0689-5_bib0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3918\/jsicm.14.77","article-title":"Efficacy of micafungin in deep-seated mycosis using \u03b2-D-glucan as indicator (in Japanese)","volume":"14","author":"Matsusashi","year":"2007","journal-title":"Journal of the Japanese Society of Intensive Care Medicine"},{"year":"2003","series-title":"Guidelines for the diagnosis and the treatment of deep-seated mycosis (in Japanese)","key":"10.1007\/s10156-009-0689-5_bib0095"},{"key":"10.1007\/s10156-009-0689-5_bib0100","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-009-0689-5_bib0105","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/clinids\/23.5.964","article-title":"Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature","volume":"23","author":"Anaissie","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-009-0689-5_bib0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01726360","article-title":"Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients","volume":"16","author":"Phillips","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-009-0689-5_bib0115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00365540410020406","article-title":"A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan","volume":"36","author":"Kohno","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1007\/s10156-009-0689-5_bib0120","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10096-005-0024-8","article-title":"International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia","volume":"24","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-009-0689-5_bib0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7164\/antibiotics.55.219","article-title":"Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus","volume":"55","author":"Hatano","year":"2002","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1007\/s10156-009-0689-5_bib0130","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/501020","article-title":"Micafungin: a new echinocandin","volume":"42","author":"Chandrasekar","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X09706750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X09706750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-009-0689-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:46:13Z","timestamp":1761158773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X09706750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"alternative-id":["S1341321X09706750"],"URL":"https:\/\/doi.org\/10.1007\/s10156-009-0689-5","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2009]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-009-0689-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}